Leukemia

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

New law funds pediatric cancer research.

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

Childhood cancer garners sympathy from all, but drug development from few.

Adult cancers are biologically different from childhood cancer, resulting in different treatments and different success rates.

Researchers explore ways to improve drug evaluations in pediatric clinical trials.

Advocates are working together to increase awareness and research in childhood cancers.

Drug development in childhood cancer has picked up the pace in recent years.

Childhood cancer survivors are at higher risk for heart disease.

Discussion of new drugs for CLL and to relieve constipation.

Igniting progress in the cure of children with cancer.

Twins' blood may explain how childhood leukemia develops.

Lu Sipos' Chemo Duck comforts childhood cancer patients.

Preventing misdiagnoses of blood cancers is all in the details.

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.

Blood counts predict leukemia survival and relapse.

Senate passes the Conquer Childhood Cancer Act for research funding.

Some cancer therapies can increase the risk of secondary cancers such as sarcoma, especially for childhood cancer survivors.

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

Delayed diagnosis too common.

Gamers take virtual shot at cancer.

Protecting bone health in childhood cancer survivors.

CML survivor Erin Zammett Ruddy wants a baby. The trade-off may be her health.

Statistics on the long-term heart effects of therapy include risk factors that increase the likelihood of heart damage in a childhood cancer survivor.

Cognitive dysfunction remains a problem for young patients.